AVMA-endorsed xylazine legislation reintroduced in CongressFebruary 20, 2025The AVMA reintroduced the Combating Illicit Xylazine Act in both the House and Senate. The legislation is reported to provide the U.S. Drug Enforcement Administration (DEA) with tools to help address the illicit drug by scheduling xylazine as a Schedule III drug, ensure common veterinary uses of the drug remain legal, help maintain the availability of the drug on the market for veterinarians, and allow the DEA to track the legitimate supply.
Education Center - SponsoredWhy Some Dogs Keep Seizing: Understanding and Managing Refractory Epilepsyby • PRN PharmacalThe severe impact of drug-resistant epilepsy highlights the importance of aiming for complete seizure control in all dogs experiencing seizures. It's crucial to enhance our understanding of the reasons behind drug resistance and how they relate to various causes, progression of the disease, and affected breeds.
